GLP-1 Supplement Ingredient Evidence August 2026

This page goes through every ingredient that commonly appears in GLP-1 and metabolic support supplements, with the same three questions applied to each: what is the mechanism, what does the human research show, and what dose did that research use. That last question is the one that decides most of these cases.

How to Read This

Two distinctions matter throughout.

Ingredient evidence is not product evidence. A study of an ingredient tells you about that ingredient at that dose in that population. It does not validate a finished product containing a different amount alongside other things.

Marker changes are not outcomes. Improving insulin sensitivity or self-reported satiety in a small trial is not the same as producing weight loss, and should not be reported as though it were.

Prebiotic and Soluble Fibers

Inulin (chicory root)

Mechanism: fermented in the colon into short-chain fatty acids, which influence gut hormone secretion including GLP-1. Genuinely the pathway the category is built on.
Evidence: human studies have examined effects on satiety hormones and appetite, with modest findings.
Research dose: commonly several grams up to around 16 g/day.
Limitation: capsule products frequently contain a few hundred milligrams — one to two percent of studied amounts. Also causes gas and bloating at higher doses.

Resistant starch

Mechanism: reaches the colon undigested and is fermented into butyrate.
Evidence: studied for insulin sensitivity, with some positive findings.
Research dose: commonly 15–30 g/day.
Limitation: the gap between that and 100 mg in a capsule is very large.

Glucomannan (konjac)

Mechanism: forms a viscous gel with water, slowing gastric emptying and adding bulk.
Evidence: the most-studied fiber for satiety; results mixed, with systematic reviews generally concluding evidence is insufficient to recommend it as a weight-loss treatment.
Research dose: 2–4 g/day before meals with water.
Limitation and safety: documented choking and oesophageal obstruction risk if taken with insufficient liquid. See our fiber guide.

Psyllium

Mechanism: viscous soluble fiber, similar to glucomannan.
Evidence: good for regularity, reasonable for cholesterol and post-meal glucose, modest for satiety.
Research dose: commonly around 5–10 g/day.
Limitation: same water precautions apply; weight effects are small.

Probiotic Strains

Akkermansia muciniphila

Mechanism: lives in the intestinal mucus layer; lower abundance observed in obesity and metabolic syndrome.
Evidence: a proof-of-concept exploratory study in Nature Medicine (2019) gave pasteurized A. muciniphila to about 32 volunteers over three months and reported improved insulin sensitivity.
Limitation: one small pilot, described as exploratory by its own authors. Genuinely interesting, not established. See our probiotics guide.

Clostridium butyricum and Bifidobacterium infantis

Mechanism: C. butyricum produces butyrate, supporting the short-chain fatty acid mechanism coherently. B. infantis is studied largely for digestive outcomes.
Evidence: mostly digestive rather than metabolic or weight-related, and strain-specific.
Limitation: findings do not transfer between strains, and most product labels do not identify strains precisely enough to check.

Berberine

Mechanism: activates AMPK, a cellular energy-sensing enzyme. Not a GLP-1 pathway.
Evidence: the strongest in this category — meta-analyses of randomized trials report reductions in fasting glucose, HbA1c, and lipid measures.
Research dose: commonly 500 mg two to three times daily, so 1,000–1,500 mg/day.
Limitations: variable trial quality, high heterogeneity, weight effects modest and inconsistent, poor oral bioavailability, and significant drug interactions via cytochrome P450 inhibition. See our berberine guide.

Chromium, Green Tea and Others

Chromium picolinate

Widely included in weight-management formulas. Reviews of chromium supplementation for body weight and appetite have generally found small, inconsistent effects that do not support it as an effective intervention. Its presence in a formula tells you little.

Green tea extract

Catechins plus caffeine have been studied for thermogenesis and fat oxidation, with small and inconsistent weight effects. There is a genuine safety note: concentrated green tea extract has been associated with rare cases of liver injury, prompting cautions from some regulatory and professional bodies about high-dose extracts.

Micronutrients

Vitamins and minerals have well-established roles and recognised deficiency states. In this category they are best understood as addressing reduced intake in people already eating much less on a GLP-1 — a coherent rationale — rather than as appetite or metabolic agents. See our companion pack review.

Summary Table

Ingredient	Evidence strength	Typical research dose	Main limitation
Berberine	Strongest here — glucose and lipids	1,000–1,500 mg/day	Drug interactions; variable trial quality
Psyllium	Good for regularity, moderate otherwise	~5–10 g/day	Small weight effects
Glucomannan	Moderate, mixed	2–4 g/day	Choking risk; reviews unsupportive for weight
Inulin	Moderate mechanism, modest outcomes	Several g up to ~16 g/day	Capsule doses far below research
Resistant starch	Moderate for insulin sensitivity	15–30 g/day	Capsule doses far below research
Akkermansia muciniphila	Early — one pilot trial	Per the pilot protocol	~32 participants; exploratory
Chromium picolinate	Weak	Varies	Small, inconsistent effects
Green tea extract	Weak, inconsistent	Varies	Rare liver injury reported with high-dose extracts

The pattern is consistent: mechanisms are real, effects are modest, doses in products are frequently below those in studies, and nothing here approaches what prescription GLP-1 medications do. Our comparison guide puts that side by side.

Frequently Asked Questions

Which GLP-1 supplement ingredient has the best evidence?

Berberine has the largest randomized trial literature, most consistently for glucose and lipid markers rather than weight. Soluble fiber has good evidence for regularity and reasonable evidence for satiety. Akkermansia muciniphila is the most scientifically interesting but rests on a single small pilot trial. None approaches the evidence base of prescription GLP-1 medications.

Why does dose matter so much in this category?

Because most capsule products contain far less of an ingredient than the studies their marketing alludes to. Research on fermentable fiber and gut hormones commonly uses several grams a day; capsules often contain a few hundred milligrams. An ingredient with good evidence at 10 g/day does not necessarily do anything at 200 mg/day.

Does chromium picolinate work for appetite?

The evidence is weak and inconsistent. Reviews of chromium supplementation for body weight and appetite have generally found small, inconsistent effects that do not support it as an effective intervention. It remains widely included in weight-management formulas nonetheless.

What about green tea extract?

Green tea catechins and caffeine have been studied for thermogenesis and fat oxidation, with small and inconsistent effects on body weight. There is a separate safety consideration: concentrated green tea extract has been associated with rare cases of liver injury, which is why some regulatory bodies have issued cautions about high-dose extracts.

Do any of these ingredients raise GLP-1 the way a medication does?

No. Fermentable fibers can influence your own GLP-1 release within the normal physiological range, in the short window after eating. Prescription GLP-1 receptor agonists sustain receptor activation for days by design. The mechanisms and magnitudes are not comparable.

Sources

Depommier et al., Nature Medicine, 2019 — Akkermansia muciniphila proof-of-concept exploratory study.
Systematic reviews and meta-analyses of glucomannan supplementation for weight and satiety outcomes.
Meta-analyses of randomized controlled trials of berberine for glycemic and lipid parameters.
Reviews of chromium supplementation for body weight and appetite outcomes.
Published case reports and regulatory communications on hepatotoxicity associated with concentrated green tea extract.
Research on colonic fermentation, short-chain fatty acid production, and gut hormone secretion.
US Food & Drug Administration — Dietary Supplements regulation and permitted claims.

Supplement Disclaimer & Review Date

These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not FDA-approved medications, are not reviewed by the FDA for safety or effectiveness before they go on sale, and are not a substitute for prescription treatment.

Nothing on this page is medical advice, and nothing here should be read as a promise of weight loss or of any particular result. Supplements can interact with prescription medications and are not appropriate for everyone. Talk to a doctor or pharmacist who knows your medical history before starting any supplement — particularly if you are pregnant or breastfeeding, take prescription medication, manage a chronic condition, or are already taking a GLP-1 medication.

Product details come from the manufacturer's own published materials as of the date below. Ingredients, amounts, pricing, and policies change frequently — check the current label and product page before purchasing.

Last reviewed: August 5, 2026

GLP-1 Supplement Ingredients – What the Evidence Shows